In its last Quarter ISAB reported a 722% increase in revenues compared to the same time last year. How will it keep up the momentum? CEO Manoush Masarrat discusses a series of major building blocks ISAB now has in place for long-term growth. ”Clinical validation of PresieInhale will expand our customer base significantly for years to come”.